PHARMA EVIDENCE ApS: Financial statements 2021
CVR: 34586519
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
PHARMA EVIDENCE ApS (CVR 34586519) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 196,010 and a net result of DKK -442,484 compared with DKK 643,333 the year before. That is a decrease of 81.7% compared with the year before. Equity in the 2021 report amounted to DKK 850,749. The solvency ratio was 64.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 196,010
- Profit/Loss
- DKK -442,484
- Equity
- DKK 850,749
- Total Assets
- DKK 1,319,748
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 196 t. | -442 t. | 851 t. | 1 |
| 2020 | - | 1.1 mio. | 643 t. | 1.3 mio. | 1 |
| 2019 | - | 749 t. | 221 t. | 650 t. | - |
| 2018 | - | 1.1 mio. | 123 t. | 429 t. | - |
| 2017 | - | 625 t. | 280 t. | 306 t. | 1 |
Official annual report
Find more companies like PHARMA EVIDENCE ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
PHARMA EVIDENCE ApS has published its annual report for 2020. Gross profit came to DKK 1,072,666, and the net result was DKK 643,333.
About PHARMA EVIDENCE ApS
PHARMA EVIDENCE ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Tove Holm-Larsen. The company is owned by HB World Holding ApS. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK 64,007 and a net result of DKK 62,147 compared with DKK -179,749 the year before. Equity in the 2025 report amounted to DKK 134,401.